首页> 中文期刊> 《食品与药品》 >普贝生用于足月引产的临床效果评价

普贝生用于足月引产的临床效果评价

         

摘要

目的 探讨普贝生用于足月妊娠引产的临床效果.方法 随机将156例足月妊娠孕妇分为两组.分别用普贝生和缩宫素引产,比较两组的宫颈评分、临产和分娩情况及不良反应.结果 普贝生组引产成功率高(96.25% vs 78.95%),临产时间缩短(10.87±5.67 vs 25.89±10.23),产程短(5.32±2.24 vs 11.92±3.12),对新生儿无不良影响.结论 普贝生用于足月引产安全、有效,对母儿无明显的不良影响.%Objective To explore the effectiveness of continuously released prostaglandin E2 suppository (propess) used for induced labor of term pregnancy. Methods A prospective case control clinical study was camed out revolved 156 cases of term pregnancies. Propess was used in 80 cases and oxytocin was used in 76 cases. The rate of cervical ripening, time from induction to delivers, duration of stage, and side effects of drags were compared betwveen the two gronps. Results Compared with oxytocin, the rate of cervical ripening was higher in propess group (96.25% vs.78.95%), with lower induction-delivery interval (10.87± 5.67 vs. 25.89± 10.23), shorter stage of labor (5.32 ±2.24 vs. 11.92 ± 3.12). No side effect was observed in the fetal and neonatal conditions of the two groups. Conclusion Propess can be used in reduced labor safely and effectively, furthermore no maternal and fetus damages are produced.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号